John N. Kapoor, Director, Officer, 10% Owner, President & CEO at Insys Therapeutics, Inc. (INSY), bought 50,000 shares at $12.41 ($642K) on 2016-05-12, disclosed to the SEC on 2016-05-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.94 | 40,000 | $518K | 80.7% |
| 2 | $12.41 | 10,000 | $124K | 19.3% |
| Total | $12.83 avg | 50,000 | $642K | 100% |
| Filing → |
| AKRX | SELL | 2014-12-12 | $2.1M | — | Filing → |
| AKRX | SELL | 2014-08-27 | $1.9M | — | Filing → |
| INSY | BUY | 2014-06-18 | $131K | — | Filing → |